Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance (Q36336801)

13 August 2017

1 reference

title

Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance (English)

1 reference

13 August 2017

author

Stephen B Kritchevsky

series ordinal

3

object named as

Stephen B Kritchevsky

1 reference

13 August 2017

4

Marco Pahor

1 reference

13 August 2017

Christy S Carter

1

1 reference

13 August 2017

Graziano Onder

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

The Journals of Gerontology

13 August 2017

published in

1 reference

13 August 2017

volume

60

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1437-1446

1 reference

Associations of body composition with physical performance and self-reported functional limitation in elderly men and women

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Effectiveness of caloric restriction in preventing age-related changes in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Gene expression profile of aging and its retardation by caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

The benefits of strength training for older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Effects of resistance training on the rate of muscle protein synthesis in frail elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Exercise dose-response effects on quality of life and independent living in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Demystifying idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Angiotensin-converting enzyme and genetics at high altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Enalapril attenuates oxidative stress in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Modulation of cutaneous inflammation by angiotensin-converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Muscle triglyceride and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Serum IL-6 level and the development of disability in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Inflammatory markers and incident mobility limitation in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Tumor necrosis factor-alpha and muscle wasting: a cellular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Humoral mediation for cachexia in tumour-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Circulating and tissue angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

The contribution of reactive oxygen species to sarcopenia and muscle ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Mitochondrial DNA mutations as a fundamental mechanism in physiological declines associated with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Aerobic power declines with aging in rat skeletal muscles perfused at matched convective O2 delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Enalapril and losartan attenuate mitochondrial dysfunction in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Valsartan for the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Underutilisation of ACE inhibitors in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

High-versus low-dose ACE inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Strength and Muscle Quality in a Well-Functioning Cohort of Older Adults: The Health, Aging and Body Composition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Elite endurance athletes and the ACE I allele--the role of genes in athletic performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F60.11.1437

Effect of captopril, losartan, and bradykinin on early steps of insulin action

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.2337/DIAB.46.12.1950

Identifiers

DOI

10.1093/GERONA/60.11.1437

1 reference

13 August 2017

1 reference